VILLARI, DONATA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.825
EU - Europa 6.959
AS - Asia 3.981
SA - Sud America 686
AF - Africa 98
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.610
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.719
RU - Federazione Russa 1.993
IT - Italia 1.947
PL - Polonia 1.273
SG - Singapore 1.198
CN - Cina 819
BR - Brasile 537
HK - Hong Kong 525
VN - Vietnam 514
IE - Irlanda 478
SE - Svezia 356
KR - Corea 347
FR - Francia 210
DE - Germania 137
FI - Finlandia 137
GB - Regno Unito 125
IN - India 120
CH - Svizzera 85
BD - Bangladesh 78
JP - Giappone 78
UA - Ucraina 75
ID - Indonesia 61
JO - Giordania 61
AR - Argentina 59
TR - Turchia 59
AU - Australia 57
NL - Olanda 56
CA - Canada 52
CI - Costa d'Avorio 33
ES - Italia 28
IQ - Iraq 28
MX - Messico 24
EC - Ecuador 20
ZA - Sudafrica 17
CO - Colombia 14
PY - Paraguay 14
UZ - Uzbekistan 13
VE - Venezuela 12
BE - Belgio 11
PE - Perù 11
UY - Uruguay 10
CL - Cile 9
NG - Nigeria 9
MA - Marocco 8
PK - Pakistan 8
NP - Nepal 7
AT - Austria 6
EG - Egitto 6
IR - Iran 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
HU - Ungheria 5
JM - Giamaica 5
KE - Kenya 5
KG - Kirghizistan 5
KZ - Kazakistan 5
MY - Malesia 5
PH - Filippine 5
RS - Serbia 5
AL - Albania 4
BJ - Benin 4
BY - Bielorussia 4
IL - Israele 4
PA - Panama 4
RO - Romania 4
AZ - Azerbaigian 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
GT - Guatemala 3
LB - Libano 3
NI - Nicaragua 3
QA - Qatar 3
TN - Tunisia 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
Totale 20.597
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.074
Warsaw 1.268
Ashburn 1.070
Singapore 876
Fairfield 687
Dublin 477
Hong Kong 432
Chandler 400
Milan 350
Seoul 340
Woodbridge 317
Wilmington 271
Seattle 266
Houston 255
Cambridge 250
San Jose 237
Lawrence 181
Altamura 178
Beijing 176
Rome 171
Los Angeles 163
Ho Chi Minh City 135
Hefei 128
Princeton 126
Buffalo 123
Florence 118
The Dalles 117
Lauterbourg 116
Hanoi 114
Ann Arbor 105
Boardman 87
Boston 86
Moscow 81
Jacksonville 79
Bern 76
Tokyo 74
Mumbai 73
Council Bluffs 69
Dallas 68
Paris 66
New York 65
Munich 56
Medford 54
Shanghai 54
São Paulo 51
Melbourne 49
Dong Ket 47
San Diego 47
Helsinki 44
Kent 44
Naples 43
Jakarta 40
Izmir 37
Abidjan 33
Turin 33
Bologna 31
Bari 30
Norwalk 26
London 25
Chicago 24
Haiphong 24
Falls Church 23
Turku 23
Figino 22
Frankfurt am Main 22
Oxford 22
Orem 20
Palermo 19
Rio de Janeiro 19
Da Nang 18
Redondo Beach 18
Barcelona 17
Guangzhou 16
Genoa 15
Modena 14
Andover 13
Clifton 13
Hillsboro 13
Reggio Emilia 13
Venice 13
Amsterdam 12
Atlanta 12
Brescia 12
Montreal 12
Ottawa 12
Toronto 12
Verona 12
Brooklyn 11
Dhaka 11
Johannesburg 11
Salvador 11
Taranto 11
Tianjin 11
Brussels 10
Thái Bình 10
Abuja 9
Biên Hòa 9
Chennai 9
Padova 9
Quito 9
Totale 13.685
Salva come PNG Salva come JPEG
Nome #
The female sexual function index (FSFI): Linguistic Validation of the Italian Version 584
RIABILITAZIONE ANDROLOGICA POST-PROSTATECTOMIA RADICALE CON TECNICA NERVE-SPARING: MODELLO TOSCANO 543
Nocturia related to post radiation bladder pain can be improved by hyaluronic acid chondroitin sulfate (ialuril®) 408
ITALIAN VALIDATION OF PELVIC PAIN AND URGENCY/FREQUENCY PATIENTS SYMPTOMS SCALE (PUF) QUESTIONNAIRE 390
Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog. 329
VOIDING SYMPTOMS, INCLUDING BLADDER PAIN, RELATED TO POST RADIATION TREATMENT FOR PCA ARE IMPROVED BY IALURIL®: A PROSPECTIVE OBSERVATIONAL STUDY 278
IMPACT OF GENDER IN NEPHRON SPARING SURGERY: COMPARISON OF PERIOPERATIVE OUTCOMES FROM THE DEFINITIVE RESULTS OF RECORD PROJECT 267
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 249
IMPACT OF GENDER IN NEPHRON-SPARING SURGERY: COMPARISON OF PERIOPERATIVE AND PATHOLOGICAL OUTCOMES FROM THE DEFINITIVE RESULTS OF RECORD1 PROJECT 237
Neoplasms in horseshoe kidneys. Apropos of 2 cases of adenocarcinoma 223
Conservative Treatment of Serous Borderline Paratesticular Tumor in a Pediatric Patient 223
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 218
Uterus-sparing vaginal surgery of genitourinary prolapse employing biocompatible material. 215
Response to Editorial Comment to Use of sigmoid colon in orthotopic neobladder reconstruction: Long-term results 211
Long-term experience with a novel uterine-sparing transvaginal mesh procedure for uterovaginal prolapse 211
Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope? 209
Minimally Invasive Transanal Repair of Rectourethral Fistulas 209
Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue 201
Conservative approach for a solitary fibrous tumor of the kidney 200
Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: preliminary experience. 199
Robotic vesico-vaginal fistula repair with no omental flap interposition 198
Ureteritis Cystica Presenting as a Single Polypoid Mass 197
Quantitative RT-PCR assay for VEGF mRNA in human tumors of the kidney. 196
Pharmacologic treatment in postprostatectomy stress urinary incontinence. 195
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. 194
Use of sigmoid colon in orthotopic neobladder reconstruction: Long-term results 191
Hypothermic Cardiac Arrest to Remove RightAtrial Thrombi Due to Abdominal Malignancies 190
Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments. 187
SIGMOID ORTHOTOPIC NEOBLADDER: LONG TERM URODYNAMICS RESULTS 186
Urinary symptoms and sexual dysfunction among Italian men: The results of the #Controllati survey 186
Coital Incontinence in Women With Urinary Incontinence: An International Study 186
Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy 185
Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: A prospective, two-center validation study. 185
Gender-related health in tuscany 183
Endoluminal stent placement after percutaneous transluminal angioplasty in the treatment of post-transplant renal artery stenosis 181
Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers 181
Weekly administration of docetaxel and epirubicin as first-line treatment for hormone refractory prostate cancer 173
Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. 173
Inflammation in Urological Malignancies: The Silent Killer 172
Editorial comment to: Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis 171
Adjuvant and salvage radiotherapy after prostatectomy: outcome analysis of 307 patients with prostate cancer. 171
Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. 168
Human bladder as a novel target for vitamin D receptor ligands. 167
Immune checkpoint inhibitors in urothelial bladder cancer: State of the art and future perspectives 167
Gender and cystectomy for bladder cancer: A high-volume tertiary urologic care center experience 165
Biological parameters for the choice of antiangiogenic therapy and efficacy monitoring 165
Renal cell carcinoma of native kidney after renal transplantation: clinical relevance of early detection. 164
Management of stage I testicular seminoma over a period of 49 years. 164
Long-term complications arising from bowel interposition in the urinary tract 164
Unmet needs of prostatectomy patients: A qualitative study in Italy 163
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities? 161
Cyclophosphamide, epirubicin and carboplatin as treatment for advanced carcinoma of the bladder: a phase II study 161
ORTHOTOPIC SIGMOID RESERVOIR: MORE THAN TWENTY YEARS EXPERIENCE 161
Flow cytometric measurement of DNA content in human solid tumors: a comparison with cytogenetics. 159
Long term urodynamics results in sigmoid orthotopic neobladder 158
The treatment of fistulae and ureteral stenosis after kidney transplantation. 157
Immunotherapy-based combinations versus standard first-line and hypothyroidism risk 156
Intrauterine device-associated actinomycosis of the ovary and urinary bladder: a case report. 154
In reply to Egger et al.: Lack of benefit from adjuvant postoperative radiotherapy and issues raised about upfront management of high- and very-high-risk prostate cancer patients 154
Adjuvant radiotherapy for a prostate cancer after renal transplantation and review of the literature. 153
Urological dysfunction in young women: an inheritance of childhood? 151
Nomogram for predicting the likelihood of postoperative surgical complications in patients treated with partial nephrectomy: a prospective multicentre observational study (the RECORd 2 project) 150
Urinary continence after nerve-sparing prostatectomy: Interference on sexual activity 149
Tissue-resonance interaction method for the noninvasive diagnosis of prostate cancer: analysis of a multicentre clinical evaluation. 149
Long term urodynamics results in sigmoid orthotopic neobladder. In: 38th Annual Meeting of the International-Continence-Society. 149
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) 148
Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study 148
Weekly paclitaxel and epirubicin in the treatment of symptomatic hormone-refractory advanced prostate carcinoma:a phase II trial 148
Radical retropubic prostatectomy for prostate cancer with microscopic bladder neck involvement: survival and prognostic implications 147
The impact of lockdown on couples’ sex lives 147
PCR-BASED DETECTION FOR MICROCHIMERISM AND GRAFT OUTCOME IN KIDNEY TRANSPLANT RECIPIENTS 146
Mixed epithelial and stromal tumour of the kidney with malignant transformation. In: XXIII Eurpoean Congress of Human Patology. 145
Our experience in the surgical treatment of oncocytoma of the kidney 145
Prostate Cancer Characteristics in Renal Transplant Recipients: A 25-Year Experience From a Single Centre 145
Potential utility of a 4-marker immunohistochemistry panel to predict response to cisplatin-based neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: a single-center preliminary experience 143
Transperitoneal vs retroperitoneal minimally invasive partial nephrectomy: comparison of perioperative outcomes and functional follow-up in a large multi-institutional cohort (The RECORD 2 Project) 143
Quantitative methylation-specific PCR of DAPK, BCL2 and hTERT genes in urine sediments of patients with bladder TCC 142
Overactive bladder syndrome before and after anterior vaginal prolapse mesh repair 140
CLINICAL, SURGICAL, PATHOLOGICAL AND FOLLOW-UP FEATURES OF KIDNEY CANCER IN PATIENTS WITH VON HIPPEL-LINDAU SYNDROME: NOVEL INSIGHTS FROM A LARGE EUROPEAN CONSORTIUM 139
Antiangiogenic drugs as chemosensitizer in genitourinary cancer 138
Retroperitoneal germ cell tumor in postmenopausal woman. 138
Female sexual life during malignancies 138
Periurethral neurofibroma. 136
Comparison of flow-cytometry and immunohistochemistry with proliferating monoclonal antibody. Cell nuclear antigen (PCNA) in the study of proliferative kinetics of renal carcinoma 136
EFFICACY OF TRANSOBTURATORY TAPE IN OBESE WOMEN 136
Anterior defect of the vaginal wall : transvaginal repair with a polypropylene mesh. 134
Synchronous bilateral testicular germ cell tumour: Case report and review of the literature 133
Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project) 129
[Our experience in the surgical treatment of oncocytoma of the kidney]. 128
Female sexual function and dysfunction Chapter 1 : Sociocultural Considerations 128
Radiotherapy after prostatectomy in high‑risk prostate cancer 125
Anterior Vaginal Defect: Transvaginal repair with a polypropylene mesh 124
Female sexual function and dysfunction 124
COITAL INCONTINENCE IN WOMEN WITH URINARY INCONTINENCE: RESULTS FROM AN INTERNATIONAL CROSS-SECTIONAL STUDY 124
Renal pseudotumors caused by retained pararenal surgical sponges. 123
Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system. 123
Sigmoid neobladder: 13-year urodynamic follow-up 123
MINI-INVASIVE TRANSRECTAL REPAIR OF RECTO-URINARY FISTULA AFTER RADICAL PROSTATECTOMY 122
Microsatellite analysis of chromosome 3p region in sporadic renal cell carcinomas. 120
Long-term biochemotherapy with cytokines and gencitabine in metastatic renal cell cancer: a phase II study 120
Totale 18.022
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.984
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022837 12 62 66 31 84 40 24 51 41 30 116 280
2022/20232.246 193 461 99 124 147 364 293 97 210 60 86 112
2023/20241.031 48 89 137 86 77 98 64 204 30 52 74 72
2024/20255.853 230 581 386 882 1.831 709 80 290 289 196 182 197
2025/20266.553 640 908 522 644 720 240 702 351 416 367 172 871
2026/202780 80 0 0 0 0 0 0 0 0 0 0 0
Totale 20.858